• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含腺癌成分的肺鳞腺癌亚型与更好的预后相关。

Adenocarcinomatous-predominant subtype associated with a better prognosis in adenosquamous lung carcinoma.

机构信息

Division of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, Province Guangdong, People's Republic of China.

Department of Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, Province Guangdong, People's Republic of China.

出版信息

BMC Cancer. 2020 Jun 5;20(1):520. doi: 10.1186/s12885-020-06972-5.

DOI:10.1186/s12885-020-06972-5
PMID:32503451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7275572/
Abstract

BACKGROUND

According to the proportion of glandular and squamous pathological components, adenosquamous carcinoma (ASC) could be divided into adenocarcinoma (AC) and squamous cell carcinoma (SCC) predominant subtypes. Due to its rarity, no study investigating the impact of different subtypes on the clinical features, radiologic findings and prognosis characteristics of ASC has been reported.

METHODS

Sixty eight patients who underwent surgical resection for lung adenosquamous carcinoma in our institute between January 2006 and March 2017 were retrospectively reviewed. Data regarding the clinical features, radiologic findings and prognosis characteristics were collected.

RESULTS

Thirty nine patients of the study cohort were with AC-predominant ASC and 29 with SCC-predominant ASC. There was no significant difference between the two subgroups in age, gender, smoking history, serum carcinoembryonic antigen (CEA) level and T,N classification. Air bronchogram was found more frequently in AC-predominant ASC than in SCC-predominant ASC (P = 0.046). Multivariate analysis identified pathological subtype (P = 0.022) and CT findings of peripheral location (P = 0.009) to be independent prognostic factors.

CONCLUSIONS

AC-predominant ASC were more commonly presented with air bronchogram, and were with a better prognosis than SCC-predominant ASC.

摘要

背景

根据腺鳞癌(ASC)中腺体和鳞状病理成分的比例,可将其分为腺癌(AC)和鳞状细胞癌(SCC)为主型。由于其罕见性,尚无研究探讨不同亚型对 ASC 的临床特征、影像学表现和预后特征的影响。

方法

回顾性分析 2006 年 1 月至 2017 年 3 月我院行手术切除的 68 例肺腺鳞癌患者的临床资料,收集患者的临床特征、影像学表现和预后特征。

结果

研究队列中有 39 例患者为 AC 为主型 ASC,29 例患者为 SCC 为主型 ASC。两组患者在年龄、性别、吸烟史、血清癌胚抗原(CEA)水平和 T、N 分期方面无显著差异。AC 为主型 ASC 中空气支气管征较 SCC 为主型 ASC 更为常见(P=0.046)。多因素分析发现,病理亚型(P=0.022)和 CT 表现为外周位置(P=0.009)是独立的预后因素。

结论

AC 为主型 ASC 更常表现为空气支气管征,且预后优于 SCC 为主型 ASC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f5f/7275572/0ea36b183800/12885_2020_6972_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f5f/7275572/a8b1c2d82edd/12885_2020_6972_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f5f/7275572/0ea36b183800/12885_2020_6972_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f5f/7275572/a8b1c2d82edd/12885_2020_6972_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f5f/7275572/0ea36b183800/12885_2020_6972_Fig2_HTML.jpg

相似文献

1
Adenocarcinomatous-predominant subtype associated with a better prognosis in adenosquamous lung carcinoma.富含腺癌成分的肺鳞腺癌亚型与更好的预后相关。
BMC Cancer. 2020 Jun 5;20(1):520. doi: 10.1186/s12885-020-06972-5.
2
Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implications.肺的腺鳞癌:外科治疗、病理特征和预后意义。
Ann Thorac Surg. 2013 Apr;95(4):1189-95. doi: 10.1016/j.athoracsur.2012.12.037. Epub 2013 Mar 6.
3
Clinicopathologic features and computed tomographic findings of 52 surgically resected adenosquamous carcinomas of the lung.52 例手术切除肺的腺鳞癌的临床病理特征和计算机断层扫描表现。
Ann Thorac Surg. 2014 Jan;97(1):245-51. doi: 10.1016/j.athoracsur.2013.09.018. Epub 2013 Nov 6.
4
Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases.肺的腺鳞癌:与鳞癌和腺癌病例的手术结果比较。
Eur J Cardiothorac Surg. 2012 Feb;41(2):357-61. doi: 10.1016/j.ejcts.2011.05.050. Epub 2011 Dec 12.
5
Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous Carcinoma: Results From a Nationwide Japanese Registry Data.切除的肺腺鳞癌的临床病理特征和生存结果:来自全国日本登记数据的结果。
Clin Lung Cancer. 2024 Sep;25(6):519-528.e3. doi: 10.1016/j.cllc.2024.05.010. Epub 2024 May 27.
6
Prognosis and survival after radical resection of primary adenosquamous lung carcinoma.原发性腺鳞癌根治性切除术后的预后与生存情况
Eur J Cardiothorac Surg. 2005 Apr;27(4):686-92. doi: 10.1016/j.ejcts.2004.12.030.
7
The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma.原发性肝鳞状细胞癌或腺鳞癌手术患者与肝细胞癌手术患者的比较。
World J Surg Oncol. 2015 Feb 28;13:90. doi: 10.1186/s12957-015-0464-2.
8
Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.肺腺鳞癌患者的临床病理特征及预后
J Huazhong Univ Sci Technolog Med Sci. 2015 Jun;35(3):350-355. doi: 10.1007/s11596-015-1436-z. Epub 2015 Jun 14.
9
[Clinicopathologic Features and Prognostic Implications in 72 Cases 
with Lung Adenosquamous Carcinoma].72例肺腺鳞癌的临床病理特征及预后意义
Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):653-658. doi: 10.3779/j.issn.1009-3419.2016.10.03.
10
Serum carbohydrate antigen 12-5 level enhances the prognostic value in primary adenosquamous carcinoma of the lung: a two-institutional experience.血清糖类抗原12-5水平增强了肺原发性腺鳞癌的预后价值:一项双机构研究经验。
Interact Cardiovasc Thorac Surg. 2016 Apr;22(4):419-24. doi: 10.1093/icvts/ivv369. Epub 2016 Jan 10.

引用本文的文献

1
Lobectomy versus sub-lobar resection for special type non-small cell lung cancer ≤2 cm.针对直径≤2cm的特殊类型非小细胞肺癌行肺叶切除术与肺段切除术的对比
J Thorac Dis. 2025 Jun 30;17(6):3797-3808. doi: 10.21037/jtd-2025-178. Epub 2025 Jun 18.
2
Durable immunotherapeutic response in molecularly complex pulmonary adenosquamous carcinoma: case report and literature review.分子复杂型肺腺鳞癌的持久免疫治疗反应:病例报告及文献综述
Front Immunol. 2025 Jun 26;16:1614283. doi: 10.3389/fimmu.2025.1614283. eCollection 2025.
3
Adenosquamous Carcinoma of the Lung: Survival, Radiologic Findings, PD-L1, and Driver Mutations.

本文引用的文献

1
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma.肺腺鳞癌的基因组起源和 EGFR-TKI 治疗。
Ann Oncol. 2020 Apr;31(4):517-524. doi: 10.1016/j.annonc.2020.01.014. Epub 2020 Jan 24.
2
Adenosquamous carcinoma of the lung.肺腺鳞癌
Onco Targets Ther. 2018 Aug 14;11:4829-4835. doi: 10.2147/OTT.S164574. eCollection 2018.
3
Improved survival associated with a balanced structure between adenomatous and squamous components in patients with adenosquamous carcinoma of the lung.肺腺鳞癌患者中,腺瘤样成分与鳞状成分之间结构平衡与生存率提高相关。
肺腺鳞癌:生存情况、影像学表现、程序性死亡受体配体1(PD-L1)及驱动基因突变
J Clin Med. 2024 Sep 25;13(19):5711. doi: 10.3390/jcm13195711.
4
Effective neoadjuvant immunotherapy and chemotherapy in stage IIIA adenosquamous carcinoma of the lung with a complete response and surgical success: A case report.III A 期肺腺鳞癌新辅助免疫治疗和化疗有效并获完全缓解及手术成功:一例报告
Oncol Lett. 2024 May 14;28(1):314. doi: 10.3892/ol.2024.14448. eCollection 2024 Jul.
5
Metastatic pattern and prognosis in patients with lung adenosquamous carcinoma: A surveillance, epidemiology, and end results-based population study.肺腺鳞癌患者的转移模式与预后:一项基于监测、流行病学及最终结果的人群研究。
Heliyon. 2024 May 6;10(9):e30641. doi: 10.1016/j.heliyon.2024.e30641. eCollection 2024 May 15.
6
Comprehensive analysis of clinicopathological profiles in adenosquamous carcinoma of the lung.肺腺鳞癌临床病理特征的综合分析
Am J Transl Res. 2024 Jan 15;16(1):126-135. doi: 10.62347/UXQC3380. eCollection 2024.
7
Distant organ metastasis patterns and prognosis of lung adenosquamous carcinoma: a SEER database analysis.肺腺鳞癌的远处器官转移模式及预后:一项监测、流行病学和最终结果(SEER)数据库分析
Interdiscip Cardiovasc Thorac Surg. 2024 Feb 2;38(2). doi: 10.1093/icvts/ivae007.
8
Bioinformatics Analysis of mRNAs and miRNAs for Identifying Potential Biomarkers in Lung Adenosquamous Carcinoma.mRNA 和 miRNA 的生物信息学分析鉴定肺腺鳞癌潜在的生物标志物。
Comput Math Methods Med. 2022 Mar 2;2022:5851269. doi: 10.1155/2022/5851269. eCollection 2022.
Eur J Surg Oncol. 2016 Nov;42(11):1699-1706. doi: 10.1016/j.ejso.2016.05.009. Epub 2016 May 25.
4
Using air bronchograms on multi-detector CT to predict the invasiveness of small lung adenocarcinoma.利用多排螺旋CT上的空气支气管征预测小肺癌的侵袭性。
Eur J Radiol. 2016 Mar;85(3):571-7. doi: 10.1016/j.ejrad.2015.12.014. Epub 2015 Dec 23.
5
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.2015 年世界卫生组织肺肿瘤分类:自 2004 年分类以来遗传、临床和放射学进展的影响。
J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630.
6
Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas.分析切除的肺腺鳞癌中的主要已知驱动突变和预后。
J Thorac Oncol. 2014 Jun;9(6):760-8. doi: 10.1097/JTO.0b013e3182a406d1.
7
Clinicopathologic features and computed tomographic findings of 52 surgically resected adenosquamous carcinomas of the lung.52 例手术切除肺的腺鳞癌的临床病理特征和计算机断层扫描表现。
Ann Thorac Surg. 2014 Jan;97(1):245-51. doi: 10.1016/j.athoracsur.2013.09.018. Epub 2013 Nov 6.
8
Adenosquamous carcinoma of the lung: CT, FDG PET, and clinicopathologic findings.肺的腺鳞癌:CT、FDG PET 和临床病理表现。
Clin Nucl Med. 2014 Feb;39(2):107-12. doi: 10.1097/RLU.0b013e3182952c2d.
9
Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implications.肺的腺鳞癌:外科治疗、病理特征和预后意义。
Ann Thorac Surg. 2013 Apr;95(4):1189-95. doi: 10.1016/j.athoracsur.2012.12.037. Epub 2013 Mar 6.
10
Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung.肺 EGFR 突变的腺鳞癌的临床病理特征。
Pathol Int. 2013 Feb;63(2):77-84. doi: 10.1111/pin.12033. Epub 2013 Feb 21.